Emerging Role of Non-Coding RNAs in Aortic Dissection

被引:11
作者
Ding, Wei [1 ]
Liu, Ying [2 ,3 ]
Su, Zhe [1 ]
Li, Qi [4 ]
Wang, Jianxun [2 ]
Gao, Yufang [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Qingdao Med Coll, Qingdao 266021, Peoples R China
[2] Qingdao Univ, Qingdao Med Coll, Sch Basic Med Sci, Qingdao 266071, Peoples R China
[3] Qingdao Univ, Affiliated Hosp, Qingdao Med Coll, Inst Translat Med, Qingdao 266021, Peoples R China
[4] Qingdao Univ, Qingdao Med Coll, Sch Nursing, Qingdao 266071, Peoples R China
基金
中国国家自然科学基金;
关键词
aortic dissection; micro RNA; long non-coding RNA; circular RNA; biomarker; therapeutic target; VASCULAR SMOOTH-MUSCLE; PHENOTYPIC SWITCH; INTERNATIONAL REGISTRY; CIRCULAR RNAS; CLINICAL-SIGNIFICANCE; DOWN-REGULATION; CELL; MICRORNAS; EXPRESSION; DIAGNOSIS;
D O I
10.3390/biom12101336
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aortic dissection (AD) is a fatal cardiovascular acute disease with high incidence and mortality, and it seriously threatens patients' lives and health. The pathogenesis of AD mainly includes vascular inflammation, extracellular matrix degradation, and phenotypic conversion as well as apoptosis of vascular smooth muscle cells (VSMCs); however, its detailed mechanisms are still not fully elucidated. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are an emerging class of RNA molecules without protein-coding ability, and they play crucial roles in the progression of many diseases, including AD. A growing number of studies have shown that the dysregulation of ncRNAs contributes to the occurrence and development of AD by modulating the expression of specific target genes or the activity of related proteins. In addition, some ncRNAs exhibit great potential as promising biomarkers and therapeutic targets in AD treatment. In this review, we systematically summarize the recent findings on the underlying mechanism of ncRNA involved in AD regulation and highlight their clinical application as biomarkers and therapeutic targets in AD treatment. The information reviewed here will be of great benefit to the development of ncRNA-based therapeutic strategies for AD patients.
引用
收藏
页数:20
相关论文
共 146 条
[1]   TCF21: a critical transcription factor in health and cancer [J].
Ao, Xiang ;
Ding, Wei ;
Zhang, Yuan ;
Ding, Dan ;
Liu, Ying .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2020, 98 (08) :1055-1068
[2]   Circular RNAs open a new chapter in cardiovascular biology [J].
Aufiero, Simona ;
Reckman, Yolan J. ;
Pinto, Yigal M. ;
Creemers, Esther E. .
NATURE REVIEWS CARDIOLOGY, 2019, 16 (08) :503-514
[3]   Non-coding RNAs in muscle differentiation and musculoskeletal disease [J].
Ballarino, Monica ;
Morlando, Mariangela ;
Fatica, Alessandro ;
Bozzoni, Irene .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (06) :2021-2030
[4]   Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy [J].
Bar, Christian ;
Chatterjee, Shambhabi ;
Thum, Thomas .
CIRCULATION, 2016, 134 (19) :1484-1499
[5]   MicroRNAs in Cardiovascular Disease [J].
Barwari, Temo ;
Joshi, Abhishek ;
Mayr, Manuel .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) :2577-2584
[6]  
Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1038/s41569-019-0227-9, 10.1161/CIRCRESAHA.115.306361]
[7]   Long Noncoding RNAs From Clinical Genetics to Therapeutic Targets? [J].
Boon, Reinier A. ;
Jae, Nicolas ;
Holdt, Lesca ;
Dimmeler, Stefanie .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (10) :1214-1226
[8]   Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes [J].
Bossone, Eduardo ;
Eagle, Kim A. .
NATURE REVIEWS CARDIOLOGY, 2021, 18 (05) :331-348
[9]   Acute aortic syndromes: diagnosis and management, an update [J].
Bossone, Eduardo ;
LaBounty, Troy M. ;
Eagle, Kim A. .
EUROPEAN HEART JOURNAL, 2018, 39 (09) :739-+
[10]   Linking Long Noncoding RNA Localization and Function [J].
Chen, Ling-Ling .
TRENDS IN BIOCHEMICAL SCIENCES, 2016, 41 (09) :761-772